Zyprexa class action given green light
Enough evidence of fraud by Eli Lilly and Co. in its marketing of Zyprexa exists to go ahead with a jury trial, a judge in New York has ruled. Plaintiffs in the case claim Lilly urged physicians to prescribe the schizophrenia and bipolar disorder drug for uses not approved by the federal government. Insurance companies, […]